Status:
UNKNOWN
Danish Evaluation of Your Heart Forecast.
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Region of Southern Denmark
Odense Patient Data Explorative Network
Conditions:
Risk Communication
Cardiovascular Risk Factor
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
Under 50% of patients diagnosed with hypertension and treated in general practice, have reached a blood pressure within the recommended levels of the national guideline. Compliance is the main problem...
Detailed Description
The project description has been shortened to fit the format of clinicaltrials.gov. Background: To improve communication of risk messages, they must be communicated in a way that is understandable a...
Eligibility Criteria
Inclusion
- All patients must understand and read Danish and must be cognitively well functioning.
- The patient must have Internet access, host an email address and read their emails on regular basis (at least once a week).
- Patients must give informed consent prior to inclusion.
- All included patients must be diagnosed with hypertension and go to regular blood pressure control consultations at their GP (at least once a year).
- Both patients with known hypertension and those newly discovered are accepted into the trial.
- Age from 35 to 75 years (both included).
- Both genders are included.
- Comorbidity is allowed with a few exceptions (see exclusion criteria).
Exclusion
- If the patient during the trial, no longer fulfils inclusion criteria 1 and/or 2, they are excluded from the trial.
- If the patient during the trial develops prolonged illness so severe that treatment of hypertension is no longer a priority, he/she will be excluded.
- Patients with blood pressure above 170/100 are excluded, as these patients should receive intensive blood pressure treatment regardless of their predicted CVD risk or heart age.
- Pregnancy.
- Very high cholesterol (TCL or TCL/HDL 8 or over).
- Genetic lipid disorders.
- If the patient is diabetic AND has a complicating kidney disease.
- Known problems with arteries to the legs defined as:
- Clinical symptoms of claudication
- Diminished foot pulses
- Carotid bruits
- Radiological evidence
- Prior surgery /percutaneous interventions
- Prior stroke or mini-stroke (TIA).
- Angina, prior AMI or heart related operation.
Key Trial Info
Start Date :
March 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04058847
Start Date
March 27 2019
End Date
December 31 2022
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Unit of General Practice, Department of Public Health, University of Southern Denmark
Odense, Region Syddanmark, Denmark, 5000